Study prompts rethink on the rise of diabetes in cities
16 November 2015 | By Victoria White
New research shows socio-cultural factors including time pressure, commuting time and where you live play significant roles in diabetes vulnerability...
List view / Grid view
16 November 2015 | By Victoria White
New research shows socio-cultural factors including time pressure, commuting time and where you live play significant roles in diabetes vulnerability...
16 November 2015 | By Victoria White
WHO's multi-country survey reveals people are confused about antibiotic resistance and do not understand how to prevent it from growing...
16 November 2015 | By Victoria White
The results come from a trial evaluating elbasvir/grazoprevir in patients with HCV infection who are receiving opioid agonist therapy...
16 November 2015 | By Victoria White
Results announced show that 95% of patients achieved a sustained virologic response at 12 weeks post-treatment...
16 November 2015 | By Victoria White
Adynovate has been shown to reduce the number of bleeding episodes during routine care...
13 November 2015 | By Victoria White
Tagrisso (AZD9291) is the only approved medicine indicated for patients with metastatic EGFR T790M mutation-positive non-small cell lung cancer...
13 November 2015 | By Victoria White
AbbVie has submitted a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) for labelling considerations based on safety and efficacy results from the Phase III HELIOS trial investigating the use of Imbruvica (ibrutinib) plus bendamustine and rituximab (BR) versus placebo plus BR in relapsed or…
13 November 2015 | By Victoria White
New data shows that overall progress towards increasing global immunisation coverage has recently stagnated...
13 November 2015 | By Victoria White
Ahead of the European Antibiotic Awareness Day, ESCMID has highlighted two of its more recent projects in the fight against antimicrobial resistance...
13 November 2015 | By Victoria White
Obizur is the first recombinant porcine sequence FVIII treatment available in Europe to treat acquired haemophilia A...
13 November 2015 | By Victoria White
A post-marketing surveillance study showed that treatment with Ofev in the real-world clinical setting had a safety profile consistent with that observed in clinical trials...
13 November 2015 | By Victoria White
The FDA has approved Harvoni for expanded use in patients with genotype 4, 5 and 6 chronic HCV infection and in patients co-infected with HIV...
13 November 2015 | By Victoria White
Roche plans to restructure its manufacturing network for small molecules to address current underutilisation as a result of its evolving portfolio...
13 November 2015 | By Victoria White
GBI Research says the rise will be driven primarily by growth in disease prevalence due to an aging global population...
Sartorius Stedim Biotech (SSB) BioOutsource today announced its expert technical staff will be speaking at and/or attending BIOLATAM, Biosimilars LATAM and Biosimilars and Biobetters conferences from November 16-19. This will provide developers of biosimilars with an excellent opportunity to discuss the optimum assay design for rapid and accurate biosimilar characterisation…